THX Pharma is set to receive total payments up to $206.1m.

THX Pharma and Biocodex strike a strategic €173 million licensing deal to advance Batten-1 and TX01 for three rare diseases ...

Biocodex has acquired two licenses from THX Pharma to develop and commercialize Batten-1 worldwide and TX01 in the United States and Canada. The total deal value is up to €173 million, including a €12 ...

THX Pharma and Biocodex have entered a strategic licensing agreement covering three rare diseases, with Biocodex acquiring rights to develop and commercialise two drug candidates across multiple ...

THX Pharma (Theranexus) and Biocodex, an independent international pharmaceutical group, today announced the execution of a strategic licensing agreement to advance the development of two drug ...

France’s THX Pharma, formerly known as Theranexus and specializing in the treatment of rare neurological diseases, and Biocodex, an independent international pharmaceutical group, announce the ...

Decades after it first boomed into theaters with its iconic, ear-splitting crescendo, THX remains a bit of an enigma for most of the public. We conducted an informal survey of some of our tech-aware ...

With a legacy rooted in cinematic excellence and iconic sound, THX Ltd. has long stood at the forefront of high-fidelity audio and video innovation. With Tuyen Pham as Chief Executive Officer, the ...

The THX Onyx DAC/Amp works with computers and smartphones to produce audiophile quality music including MQA files. This is the first product THX has made to sell directly to consumers and uses THX AAA ...